Zolimidine
Подписчиков: 0, рейтинг: 0
|
| |
|
| |
| Names | |
|---|---|
|
Preferred IUPAC name
2-[4-(Methanesulfonyl)phenyl]imidazo[1,2-a]pyridine | |
| Identifiers | |
|
3D model (JSmol)
|
|
| ChemSpider |
|
| ECHA InfoCard | 100.013.589 |
| KEGG |
|
|
PubChem CID
|
|
| UNII | |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C14H12N2O2S | |
| Molar mass | 272.32 g/mol |
| Density | 1.31 g/cm3 |
| Pharmacology | |
| A02BX10 (WHO) | |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Zolimidine (zoliridine, brand name Solimidin) is a gastroprotective drug previously used for peptic ulcer and gastroesophageal reflux disease.
See also
| H2 antagonists ("-tidine") | |
|---|---|
|
Prostaglandins (E)/ analogues ("-prost-") |
|
|
Proton-pump inhibitors ("-prazole") |
|
|
Potassium-competitive acid blockers ("-prazan") |
|
| Others | |
| Combinations | |
| |